myelofibrosis

Showing NaN - NaN of 11

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Myelofibrosis Trial in Worldwide (BMS-986158, Ruxolitinib, Fedratinib)

Recruiting
  • Myelofibrosis
  • La Jolla, California
  • +36 more
Jan 13, 2023

Myeloproliferative Disorders, Myelofibrosis, Primary Myelofibrosis Trial in Worldwide (ACE-536, Placebo)

Recruiting
  • Myeloproliferative Disorders
  • +4 more
  • La Jolla, California
  • +184 more
Aug 22, 2022

Myelofibrosis Trial in Worldwide (Imetelstat 4.7 mg/kg, Imetelstat 9.4 mg/kg)

Completed
  • Myelofibrosis
  • Imetelstat 4.7 mg/kg
  • Imetelstat 9.4 mg/kg
  • Birmingham, Alabama
  • +71 more
Aug 17, 2021

Myelofibrosis Trial in Stanford, Ann Arbor (Idelalisib, Ruxolitinib)

Terminated
  • Myelofibrosis
  • Stanford, California
  • +1 more
Aug 31, 2020

Lymphoma, Large B-Cell, Diffuse, Lymphoma, Mantle-Cell, Lymphoma, Follicular Trial in Argentina, United States (ASN002 Dose

Terminated
  • Lymphoma, Large B-Cell, Diffuse
  • +20 more
  • ASN002 Dose Escalation
  • ASN002 RD
  • Tempe, Arizona
  • +13 more
Aug 13, 2018

Myelofibrosis Trial in United States (SAR302503 (TG101348))

Completed
  • Myelofibrosis
  • SAR302503 (TG101348)
  • La Jolla, California
  • +5 more
Feb 17, 2016

Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Chronic Myelogenous Leukemia Trial in Ann Arbor (TAK-901)

Completed
  • Acute Myeloid Leukemia
  • +11 more
  • Ann Arbor, Michigan
    University of Michigan
Jul 1, 2013

Myelofibrosis Trial in United States (TG101348)

Completed
  • Myelofibrosis
  • San Diego, California
  • +5 more
Oct 22, 2009